Table 2.
Marketers of generic DAAs
| Marketer | Number of patients | ||
|---|---|---|---|
| SOF | DCV | LDV | |
| Cipla | 192 | 89 | 105 |
| Hetero | 182 | 103 | 70 |
| Natco | 45 | 17 | 16 |
| Mylan | 41 | 9 | 15 |
| West Linfield Pharmacy (Compounded API) | 12 | 3 | 11 |
| Sun Pharma | 18 | 9 | 8 |
| Incepta | 8 | 0 | 8 |
| Mesochem | 10 | 15 | 4 |
| Other | 3 | 9 | 4 |
| Zydus | 22 | 25 | 3 |
| Pharmed Healthcare | 3 | 0 | 3 |
| UTH | 3 | 0 | 3 |
| Chinese API | 3 | 31 | 1 |
| Beacon | 1 | 1 | 1 |
| Dr. Reddy's | 1 | 1 | 1 |
| Marcyrl | 6 | 5 | 0 |
| Strides Arcolab | 12 | 2 | 0 |
| Emcure | 5 | 0 | 0 |
| Aark Pharmaceuticals | 0 | 0 | 0 |
| Augispov | 1 | 0 | 0 |
| Beximco | 1 | 0 | 0 |
| Pharco Corporation | 1 | 0 | 0 |
| No data available | 46 | 21 | 23 |
DCV: daclatasvir; LDV: ledipasvir; SOF: sofosbuvir